[Fiberoptic phototherapy of neonatal jaundice. Comments to a Cochrane report].
Twenty-four studies filled the inclusion criteria for a Cochrane report on the use of fiberoptic phototherapy for neonatal jaundice. Fiberoptic phototherapy lowers serum bilirubin and may have a place in the treatment of neonatal jaundice. In term and near-term infants fiberoptic phototherapy is inferior to conventional phototherapy, whereas in premature infants the effects are comparable. A better effect is achieved when conventional and fiberoptic phototherapy are combined as compared to conventional phototherapy alone. Fiberoptic phototherapy has not been shown to interfere less with parent-infant bonding than conventional phototherapy. There continues to be a great need for research concerning phototherapy for neonatal jaundice.
Hansen
T W
TW
Nyfødtseksjonen, Barneklinikken, Rikshospitalet, Oslo, Norge. t.w.r.hansen@klinmed.uio.no
D019317:Evidence-Based Medicine; D005336:Fiber Optic Technology; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007567:Jaundice, Neonatal / Q000628:therapy*; D015201:Meta-Analysis as Topic; D010287:Parent-Child Relations; D010789:Phototherapy / Q000379:methods* / Q000523:psychology